Newsroom > Articles


We are pleased to announce the arrival of Julie Baussand as Director of Health Innovation Projects.

With an academic background in bioinformatics, Julie has worked with private, public and associative actors in the health sector. She has acquired a broad vision of the challenges facing the healthcare innovation sector, as well as an excellent knowledge of the expectations and needs of the players in the ecosystem. Julie’s mission is to develop the Medexprim network and to federate and coordinate public and private actors around research projects integrating Real-World Data to address clinical issues.  

Romain Cazavan, CEO: “Julie brings her expertise and network in innovative health technologies, acquired in particular through the central position she held with great success within the Medicen Paris Region cluster. These are new assets to reinforce Medexprim’s position as a strong player in the still emerging health data ecosystem. She joins Nicolas Dubost, Cristina D’Almeida and Pascal Sempé to strengthen a solid team and anchor Medexprim’s solutions in structuring projects for the entire industry, in France and in Europe. “

Julie Baussand: “Joining Medexprim is a great opportunity to continue serving the healthcare innovation industry, which I find inspiring and exciting. Medexprim’s value proposition offers a huge potential for promising synergies to lead to truly impactful achievements for healthcare professionals and patients. I’m thrilled to join this technically and strategically strong and humanly warm team, two factors that are very important to me.”

French version of the PR

About Medexprim:
Medexprim is Europe’s leading provider of secure imaging and clinical data extraction to accelerate medical research. As a real-world data specialist, we build bridges between leading academic hospitals and pharmaceutical, AI and medical device companies. In compliance with the GDPR, we help hospitals drive their own clinical research strategy and extract value from their data, through our software and services designed with and for clinicians. We provide our partners with secure access to regulatory-grade data. Medexprim aims to build multicentric disease-specific data lakes to serve oncology, neurology and cardiology. We help solve the “one patient, one disease, one treatment” equation to develop precision medicine for better care.

Linkedin Romain Cazavan
Linkedin Julie Baussand

Medexprim Press contact: Anne-Sophie Labeta

RSNA 2023: Medexprim brings European multi-imaging datasets to Innovation.

Medexprim, a leading European innovator in the field of Real-World Data and healthcare solutions,…

IQVIA clôture l’édition 2023 de son Accelerator Program, en collaboration…

IQVIA, spécialiste mondial d’analyses avancées, de solutions technologiques et de services de recherche clinique…

RSNA 2023: Medexprim brings European multi-imaging datasets to Innovation

Medexprim is set to showcase its cutting-edge, regulatory-grade multi-imaging and multimodal datasets at RSNA…

ESMO Congress 2023, D-1 / Medexprim spearheads Real-World Data to…

Medexprim, a leading innovator in the field of Real-World Data and healthcare solutions, is…